Latest filing published 24 Sept 2026 for Tango Therapeutics, Inc., €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Jessica Newcomb in Tango Therapeutics, Inc. The record holds 3 filings, all for trades on 22 September 2026.
No open-market purchase appears, only 3 sales worth €173k.
Most recently, on 24 September 2026, the filings show an open-market sale worth €14k in Tango Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations